Glipizide
- Product NDC
- 0615-7968
- 11-digit product format
- 006157968
- Labeler code
- 0615
- Product ID
- 0615-7968_4709ffc5-3eee-4a84-b1d9-cc6fd27e9852
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA075795
- Marketing category
- ANDA
- Marketing start
- 2002-09-25
- Marketing end
- 2023-04-30
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-7968-05 | 00615796805 | 15 TABLET in 1 BLISTER PACK (0615-7968-05) | 15 tablet | 2018-09-06 | 2023-04-30 | No | No | Current |
| 0615-7968-30 | 00615796830 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7968-30) > 5 TABLET in 1 BLISTER PACK | 6 blister pack | 2018-12-03 | 2023-01-31 | No | No | Current |
| 0615-7968-39 | 00615796839 | 30 TABLET in 1 BLISTER PACK (0615-7968-39) | 30 tablet | 2018-09-06 | 2023-04-30 | No | No | Current |